Biophysical Corporation announced today that it has partnered with Amcare Labs International, Inc., an affiliate of Johns Hopkins Medicine International, to offer the Biophysical250 health assessment at the Tokyo Midtown Medical Center in Tokyo, Japan. Tokyo Midtown Medical Center has exclusive rights in Japan to offer the Biophysical250 to their patients.
Biophysical Corporation's Biophysical250 is an innovative health assessment that provides the single most comprehensive evaluation of an individual's health available to date. Compared
with standard physicals that typically only look at 20-40 biomarkers (proteins in the blood like glucose and cholesterol), Biophysical250 measures those same biomarkers, plus those used
routinely by 12 different medical specialties, including cardiology, oncology and rheumatology, for a total of more than 250 different biomarkers. With a blood sample of approximately two
tablespoons, the Biophysical250 provides an assessment that can help indicate the presence of certain diseases and medical conditions at their earliest stages, often before symptoms
appear.
"We are delighted to work with innovators in the medical assessment field such as Biophysical Corporation and are pleased that the Biophysical250 will be used by the Tokyo Midtown Medical
Center and available in Japan," said Mohan Chellappa, president of Amcare Labs International.
Amcare is in the business of helping clinical labs and medical facilities throughout the world define a new standard of excellence in global medicine by implementing the best laboratory
and pathology technologies developed in the United States. Tokyo Midtown Medical Center recommends Biophysical250 to patients who want a comprehensive assessment of their health.
"Our mission is to provide the highest level of medical care in Japan," said Tetsuya Furukawa, president and COO of Tokyo Midtown Medical Center. "After months of careful evaluation we
concluded that Biophysical250 is not only the best way to assess an individual's current state of health, but also to track improvement. The results provide our physicians with a
comprehensive biomarker analysis that serves as the scientific foundation for further tests that can ultimately lead to the earlier detection of potentially serious conditions and
diseases and the development of more effective treatment plans. We are fortunate to have expert guidance from our international partners as we evaluate new medical technologies such as
Biophysical250 to benefit our patients. "
Tokyo Midtown Medical Center opened in March 2007 to provide Japanese and foreign executives with world-class medical care and health and wellness programs offered in a luxury
environment. As Japan's first affiliation with John Hopkins Medicine International, Tokyo Midtown Medical Center is a comprehensive medical facility that incorporates the most technically
advanced medical technology to assess and optimize quality of life for busy executives through thorough health screening, customized physical examinations and personalized health and
wellness programs. Located in prestigious Tokyo Midtown, a new-style urban district that features Midtown Tower, the tallest structure in Tokyo, Tokyo Midtown Medical Center is situated
at a "global crossroads" in Tokyo's major international business and cultural district that includes over 40 foreign embassies within a mile radius.
"Partnering with Amcare Labs with its affiliation to Johns Hopkins Medicine International provides us entry into unlimited international markets," said George Rodgers, president and chief
medical officer for Biophysical Corporation. "We're pleased that our first international partner is Tokyo Midtown Medical Center, an outstanding state-of-the-art health and wellness
facility that shares our philosophy on prevention and early detection."
About Amcare Labs International:
Founded in 2001, Amcare Labs International provides physicians, its partner labs, patients and institutions with the highest quality clinical and educational services available to assist
people in obtaining true health through the adoption of the world's top medical technology. Through its unique affiliation with the clinical labs of Johns Hopkins Hospital and Johns
Hopkins University, Amcare offers a broad array of tests and interpretations of medical information to its partner labs in international communities. More information about Amcare Labs is
located at http://www.tokyo-midtown.com/en/facilities/medical/index.html
About Biophysical Corporation:
Biophysical Corporation is a private, Austin, Texas-based company dedicated to advancing clinical knowledge and quality of life for its clients. Formed in 2004, the company offers
Biophysical250, the most comprehensive and advanced assessment of personal health ever developed. Through the innovative analysis of blood-based biomarkers, Biophysical250 may indicate
the presence or risk of cancer, cardiovascular disease and other health risks often before symptoms appear. The company's management and advisory board includes internationally renowned
physicians and scientists who are leaders in the field of biomarker research. More information about the company and Biophysical250 is available at